News Virbac

Equities

Real-time Euronext Paris Other stock markets 03:11:08 2024-04-25 am EDT			5-day change	1st Jan Change
359.5 ^EUR	-0.14%		-3.35%	+0.28%

Apr. 17	VIRBAC : A healthy start to 2024; outlook re-iterated
Apr. 17	Virbac: sales up by almost 10% in Q1	CF

Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)	Apr. 24	GL
VIRBAC : A healthy start to 2024; outlook re-iterated	Apr. 17
Virbac: sales up by almost 10% in Q1	Apr. 17	CF
VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates	Apr. 16	GL
Virbac SA Announces Revenue Results for the First Quarter of 2024	Apr. 16	CI
Virbac : Déclaration d'actions et de droits de vote 03/2024	Apr. 09	PU
Virbac: 'strategic' acquisition of Sasaeah in Japan	Apr. 02	CF
Virbac acquired Sasaeah, a leading animal health player in Japan	Apr. 02	GL
Virbac SA acquired Sasaea Holdings Co., Ltd. from ORIX Corporation.	Mar. 31	CI
VIRBAC : Oddo BHF maintains its recommendation on the stock	Mar. 21	CF
CAC40: damage limited despite Kering's fall	Mar. 20	CF
Transcript : Virbac SA, 2023 Earnings Call, Mar 20, 2024	Mar. 20
Virbac: net income unchanged overall in 2023	Mar. 20	CF
Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023	Mar. 19	GL
Virbac : Consolidated accounts_2023	Mar. 19	PU
VIRBAC: 2023 ANNUAL RESULTS	Mar. 19	GL
VIRBAC: 2023 ANNUAL RESULTS	Mar. 19	AQ
Virbac Sa Provides Earnings Guidance for the Year 2024	Mar. 19	CI
Virbac Sa Proposes Dividend for the Year 2023	Mar. 19	CI
Virbac SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI

No results for this search

VIRBAC : A healthy start to 2024; outlook re-iterated

April 17, 2024 at 12:39 pm EDT